As lawyers, we have to get client approval before we can discuss their litigation substantively. Here are a couple just-in decisions where we’re doing that, but that are important enough our readers would want to know about them right away. In re Incretin-Based Therapies Products Liability Litigation, slip op. (S.D. Cal. Nov. 9, 2015) (win on Levine “clear evidence” prescription drug preemption); In re Testosterone Replacement Therapy Products Liability Litigation, slip op. (N.D. Ill. Nov. 9, 2015) (win on generic drug preemption involving reference listed drugs).